| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3C39BY17Y6 |
Structure
| InChI Key | JDLKFOPOAOFWQN-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C6H10OS2 |
| Molecular Weight | 162.28 |
| AlogP | 1.76 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 17.07 |
| Molecular species | None |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 9.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Cysteine protease
Cysteine protease CA clan
Cysteine protease C1A family
|
- | - | - | 5310 | - | |
|
Enzyme
Transferase
|
- | 500 | - | - | - | |
|
Ion channel
Ligand-gated ion channel
Epithelial sodium channel
|
- | - | - | - | 77 | |
|
Ion channel
Voltage-gated ion channel
Transient receptor potential channel
|
1320 | - | - | - | - | |
|
Unclassified protein
|
- | 11 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 28411 |
| ChEMBL | CHEMBL359965 |
| DrugBank | DB11780 |
| EPA CompTox | DTXSID6043707 |
| FDA SRS | 3C39BY17Y6 |
| Human Metabolome Database | HMDB0033963 |
| Guide to Pharmacology | 2419 |
| KEGG | C07600 |
| PubChem | 65036 |
| SureChEMBL | SCHEMBL2920 |
CONTENTS